Cargando…
Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified as an unambiguous cause of late-onset, autosomal-dominant familial Parkinson’s disease (PD) and LRRK2 mutations are the strongest genetic risk factor for sporadic PD known to date. A number of transgenic mice expressing...
Autores principales: | Xiong, Yulan, Neifert, Stewart, Karuppagounder, Senthilkumar S., Stankowski, Jeannette N., Lee, Byoung Dae, Grima, Jonathan C., Chen, Guanxing, Ko, Han Seok, Lee, Yunjong, Swing, Debbie, Tessarollo, Lino, Dawson, Ted M., Dawson, Valina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355896/ https://www.ncbi.nlm.nih.gov/pubmed/28321439 http://dx.doi.org/10.1523/ENEURO.0004-17.2017 |
Ejemplares similares
-
Parthanatos Mediates AIMP2 Activated Age Dependent Dopaminergic Neuronal Loss
por: Lee, Yunjong, et al.
Publicado: (2013) -
Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021) -
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014) -
Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons
por: Jiang, Haisong, et al.
Publicado: (2016) -
PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
por: Pirooznia, Sheila K., et al.
Publicado: (2020)